Headlines

This Analyst Says Orthopedic-Focused Orthofix Medical Is Positioned For Growth

Canaccord Genuity initiates coverage on Orthofix Medical with a Buy rating and $24 price target, citing growth potential and strong financial outlook.

Latest Ratings for OFIX

Date Firm Action From To
Mar 2022 Stifel Upgrades Hold Buy
Oct 2020 Stifel Initiates Coverage On Hold
Feb 2020 Sidoti & Co. Maintains Buy

View More Analyst Ratings for OFIX

View the Latest Analyst Ratings

read more

Leave a Reply

Your email address will not be published. Required fields are marked *